Delivery Order 36F79720D0237-36C24825N0317
Award Date
1/15/25
Potential Completion Date
1/14/26
Potential Value
$232K
Federal Agency
Veterans Integrated Service Network 8
Ultimate Awardee
Bayer AG
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Whippany, Hanover, NJ 07981, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Xofigo (radium Ra 223 dichloride), a specialized pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The order has a ceiling value of $213,438.96 and was placed through the VA's National Acquisition Center. The...
This federal contract award is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) to the Department of Veterans Affairs (VA) and other federal agencies. The contract, valued at $510,000.00, was awarded to the prime contractor Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract is a Delivery Order placed under Bayer's existing $840 million multiple award Federal Supply Schedule contract with the VA for...
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization, for the delivery of Xofigo (radium Ra 223 dichloride) injection, a radiopharmaceutical product used for the treatment of prostate cancer. The contract, valued at $75,087.37, was awarded by the Department of Veterans Affairs (VA) under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The contract is a delivery order, with a firm fixed price...
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit company, for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract, with a ceiling value of $302,784.30, is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The award has no set-aside designation, and the place...
This is a federal contract award by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The contract is for the delivery of Xofigo (radium Ra 223 dichloride) injections, a specialized pharmaceutical product used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and a ceiling value of $111,938.48. The...
This is a federal contract award issued by the U.S. Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The contract, valued at $95,178.59, is for the delivery of the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) injection, which is used for the treatment of prostate cancer. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, with a...
This federal contract award is for the delivery of Xofigo (radium Ra-223 dichloride injection) to the Department of Veterans Affairs (VA). The contract has a period of performance from February 1, 2018, to July 31, 2018, with a ceiling value of $77,056.79. The contract was awarded to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization that specializes in pharmaceutical products and medical supplies. The contract was awarded under the VA's Pharmaceuticals and Drugs...
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract, valued at $254,309.88, is for the delivery of Xofigo (radium Ra 223 dichloride) injection, a radiopharmaceutical used to treat prostate cancer. The contract is a delivery order under Bayer's existing VA Federal Supply Schedule contract for Pharmaceuticals and Drugs. The contract has no set-aside...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a subsidiary of the global pharmaceutical company Bayer AG. The contract, worth $89,775.53, is for the supply of the radiopharmaceutical medication Xofigo (radium Ra 223 dichloride) for the treatment of prostate cancer. The contract was awarded under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which has a potential...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit organization. The $95,296.85 firm fixed price delivery order is for the radiopharmaceutical product Xofigo (radium Ra 223 dichloride), which is used to treat prostate cancer. The award is part of Bayer's $840 million multiple award Federal Supply Schedule contract with the VA for Pharmaceuticals and Drugs. This contract vehicle allows various...